PCLO.V - PharmaCielo Ltd.
TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD
Valuation Measures
| Market Cap (intraday) 5 | 279.7M |
| Enterprise Value 3 | 250.71M |
| Trailing P/E | N/A |
| Forward P/E 1 | 54.80 |
| PEG Ratio (5 yr expected) 1 | N/A |
| Price/Sales (ttm) | 2,149.43 |
| Price/Book (mrq) | 5.57 |
| Enterprise Value/Revenue 3 | 1,926.60 |
| Enterprise Value/EBITDA 6 | -9.97 |
Trading Information
Stock Price History
| Beta (3Y Monthly) | N/A |
| 52-Week Change 3 | ∞% |
| S&P500 52-Week Change 3 | 18.89% |
| 52 Week High 3 | 11.5000 |
| 52 Week Low 3 | 2.5100 |
| 50-Day Moving Average 3 | 3.1925 |
| 200-Day Moving Average 3 | 4.9680 |
Share Statistics
| Avg Vol (3 month) 3 | 136.45k |
| Avg Vol (10 day) 3 | 90.72k |
| Shares Outstanding 5 | 97.49M |
| Float | 78.58M |
| % Held by Insiders 1 | N/A |
| % Held by Institutions 1 | N/A |
| Shares Short (Nov 15, 2019) 4 | 3.29M |
| Short Ratio (Nov 15, 2019) 4 | 21.79 |
| Short % of Float (Nov 15, 2019) 4 | N/A |
| Short % of Shares Outstanding (Nov 15, 2019) 4 | 3.37% |
| Shares Short (prior month Oct 15, 2019) 4 | 3.46M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor (new per old) 2 | 11/1 |
| Last Split Date 3 | Jan 18, 2019 |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2018 |
| Most Recent Quarter (mrq) | Sep 30, 2019 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -20,512.69% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 130.13k |
| Revenue Per Share (ttm) | 0.00 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -36.64k |
| EBITDA | -25.15M |
| Net Income Avi to Common (ttm) | -31.22M |
| Diluted EPS (ttm) | -0.3410 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.8M |
| Total Cash Per Share (mrq) | 0.21 |
| Total Debt (mrq) | 1.38M |
| Total Debt/Equity (mrq) | 2.87 |
| Current Ratio (mrq) | 5.21 |
| Book Value Per Share (mrq) | 0.49 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26.84M |
| Levered Free Cash Flow (ttm) | N/A |